MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of cancer therapy. This article presents evidence‐based clinical practice guidelines for the management of mucositis.

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Lalla, Rajesh V., Bowen, Joanne, Barasch, Andrei, Elting, Linda, Epstein, Joel, Keefe, Dorothy M., McGuire, Deborah B., Migliorati, Cesar, Nicolatou‐Galitis, Ourania, Peterson, Douglas E., Raber‐Durlacher, Judith E., Sonis, Stephen T., Elad, Sharon
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wiley 2014
Pynciau:
Review Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4164022/
https://ncbi.nlm.nih.gov/pubmed/24615748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28592
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg